Genentech remunerates Xencor; XPrize upraises f...

The world's first genetic sequencing of precancerous lung lesions could pave the way for very early detection and new treatments report a new study led by UCL researchers. Before lung cancer develops, precancerous lesions are found in the airway, but only half of these will actually become lung cancer, while others...

BridgeBio bags USD 299 Million for genetic diseases BridgeBio Pharma has received a USD299.2 million for its progress in genetic disease pipeline. This includes assets in preclinical and clinical development. Several therapeutic areas are being taken under the consideration of the pharma. Also, th...

Stopping breast cancer metastasis by killing tumor cells in their sleep Oncology researchers believed that dormant breast cancer cells are not responsive to chemotherapy. But these inactive cancer cells can be active at any time and cause life-threatening metastases. Scientists at the Fred Hutchinson Cancer Rese...

Ladies, January is the month of raising awareness about cervical cancer. In the US, 250000 women are affected every year. One can refrain from the cancer by avoiding human papillomavirus, or HPV, which is sexually transmitted. We can eliminate cervical cancer as a public health problem through intensified vaccinati...

Doctors now have a new weapon in the fight against cancer: detailed maps of the cells in a tumour that can be explored and analyzed in a virtual reality simulation that its creators say provides researchers with an intuitive new way to examine complex medical data that could lead to unexpected breakthroughs. Bui...

A survey was done in which thousands of advanced cancers indicated a way to detect those that respond to revolutionary therapies that unleash an immune response against tumours. However, the results show difficulty level to translate an approach into a reliable clinical test. The findings are the latest evidence to...